Valeant Pharmaceuticals International, Inc. (VRX)
-NYSE 85.86 
1.04(1.23%) Jun 18, 4:03PM EDT|After Hours
:
85.98 0.12 (0.14%) Jun 18, 7:59PM EDT
| Prev Close: | 84.82 |
|---|
| Open: | 83.86 |
|---|
| Bid: | 85.65 x 200 |
|---|
| Ask: | 85.99 x 100 |
|---|
| 1y Target Est: | 52.38 |
|---|
| Beta: | 0.94 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 83.86 - 88.67 |
|---|
| 52wk Range: | 42.47 - 96.25 |
|---|
| Volume: | 2,443,519 |
|---|
| Avg Vol (3m): | 1,772,400 |
|---|
| Market Cap: | 26.26B |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.43 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior NotesCNW Group(Tue, Jun 18)
- Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior NotesPR Newswire(Tue, Jun 18)
- Valeant Pharmaceuticals Prices Public Offering Of Common SharesCNW Group(Tue, Jun 18)
- Valeant Pharmaceuticals Prices Public Offering Of Common SharesPR Newswire(Tue, Jun 18)
- The Top 3 Medical Uses of Botoxat Motley Fool(Tue, Jun 18)
- Stocks Rally Ahead Of Fed; Cree Clears 3-Weeks-Tightat Investor's Business Daily(Tue, Jun 18)
- Stocks Add To Gains; United Rentals Snaps Backat Investor's Business Daily(Tue, Jun 18)
- What are insiders buying these days?at MarketWatch(Tue, Jun 18)
- Stocks Open Up In Light Trade; FLIR Systems Bolts Higherat Investor's Business Daily(Tue, Jun 18)
- Early Movers: SFD, SNE, BA, SKUL, HOST & Moreat CNBC(Tue, Jun 18)
- VALEANT PHARMACEUTICALS INTERNATIONAL, INC. Files SEC form 8-K/A, Other Events, Financial Statements and ExhibitsEDGAR Online(Tue, Jun 18)
- 4 Healthcare Stock Stories Making Waves On Mondayat Wall St. Cheat Sheet(Mon, Jun 17)
- Valeant Pharma plans $1.75B stock offeringAP(Mon, Jun 17)
- After-Hours Buzz: Korn/Ferry, Host Hotels, Campbell Soup & Moreat CNBC(Mon, Jun 17)
- InPlay: Valeant Pharma announces public offering of common shares to raise gross proceeds of ~$1.75 blnBriefing.com(Mon, Jun 17)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 6.90 |
|---|
| Ex-Dividend Date: | 10-Nov-10 |
|---|
Analysts
| Annual EPS Est
(Dec-10)
: | N/A |
|---|
| Quarterly EPS Est
(Sep-10)
: | N/A |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Valeant Pharmaceuticals International, Inc., a specialty pharmaceutical company, develops, manufactures, and markets pharmaceutical products and medical devices in the areas of neurology, dermatology, and branded generics.
View More